title: [Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T].
authors.forename: I
authors.initials: I
authors.lastname: Kadowaki
authors.forename: O
authors.initials: O
authors.lastname: Sasaki
authors.forename: T
authors.initials: T
authors.lastname: Sasaki
authors.forename: K
authors.initials: K
authors.lastname: Ishizawa
authors.forename: J
authors.initials: J
authors.lastname: Kimura
authors.forename: J
authors.initials: J
authors.lastname: Nomura
authors.forename: K
authors.initials: K
authors.lastname: Furuyama
authors.forename: H
authors.initials: H
authors.lastname: Harigae
authors.forename: T
authors.initials: T
authors.lastname: Shishido
authors.forename: M
authors.initials: M
authors.lastname: Okuda
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000473:pathology / Q000628:therapy*; D001088:Arabinonucleotides / Q000008:administration & dosage*; D003568:Cytidine Monophosphate / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D011355:Prodrugs; D012074:Remission Induction
chemical_list: D001088:Arabinonucleotides; D011355:Prodrugs; D016179:Granulocyte Colony-Stimulating Factor; C061162:1-arabinofuranosylcytosine-5'-stearylphosphate; D003568:Cytidine Monophosphate